After becoming Omicron It’s a variant of Covid taking over the world, and it’s taking many forms. First there is BA.1, then BA.5, and finally he has BQ.1 and BQ.1.1 and so on. XBB.1.5, also known as the Kraken, has swept the Northeastern United States in recent weeks.
The World Health Organization (WHO) considers XBB.1.5 to be the most contagious version of the Omicron variant to date and announces that countries should consider recommending masks in dangerous situations such as flights Did. It’s quickly becoming dominant in parts of the United States, and some experts fear it could fend off immunity from past infections and possibly vaccines.
Each time a new variant snowballs in at a rapid rate, it grabs attention. Severe mutations in the SARS-CoV-2 virus could mean more illness, hospitalizations, and deaths, straining healthcare systems and increasing long-term Covid incidence. While XBB.1.5 infections are on the rise, the WHO says there is no evidence that mutations in this variant cause more severe infections, although it is still in its early stages. Hospitalizations are on the rise, but are far from peaking in early 2022. Still, the rise of the fast-moving variant has refocused attention on the ongoing problem: how should vaccines be updated? It is
Pavitra Roychoudhury, Director of Covid-19 Sequencing, University of Washington Virology, said: Lab. Roychoudhury said it’s important to identify variants early and look at how future vaccines can be designed. It may be circulating at a high frequency. ”
This variant is a substrain of two other Omicron offshoot recombinants. That mixing can occur if a person is infected with two of his subspecies of the virus at the same time, or if the two meet in wastewater.
This could lead to some prevalent cases if it turns out to have two advantages: its ability to evade antibodies acquired from past infections and vaccinations, and its ability to bind to the ACE2 receptor, which allows Covid to enter cells. may stand out among the Omicron subspecies of . and infect humans. A preprint submitted in early January by a Chinese researcher focusing on XBB.1.5 claimed to be so, although the paper has not yet been published or peer-reviewed. .
“It’s like a one-two punch of mutation,” says Peter Hotez, co-director of the Texas Children’s Hospital Vaccine Development Center and dean of the National School of Tropical Medicine at Baylor College of Medicine. “Not only did it have immune escape properties, it was able to do so while maintaining its ability to bind to its receptors.”
Fewer people are wearing masks than in 2020, and many are traveling or gathering indoors to celebrate the holiday season. It’s a recipe for many to get sick quickly. It’s starting to work even when you remove most of it,” says Stephanie Silvera, an epidemiologist and professor of public health at Montclair State University in New Jersey.
